Valuation Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse

Stocks

End-of-day quote Wiener Boerse 10/09/2026			5-day change	1st Jan Change
57.40 ^EUR	-0.43%		-2.79%	-9.32%

23/07	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
23/07	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	4,138	1,925	3,213	3,220	3,248	2,933	-	-
Change	-	-53.49%	66.93%	0.22%	0.87%	-9.7%	-	-
Enterprise Value (EV) ¹	4,112	1,872	3,251	3,305	3,272	2,917	2,852	2,740
Change	-	-54.48%	73.7%	1.65%	-1%	-10.85%	-2.24%	-3.93%
P/E	26.7x	9.67x	18.8x	23.6x	23.1x	20.5x	16.9x	13.8x
PBR	8.59x	3.71x	5.94x	5.63x	4.89x	3.9x	3.34x	2.86x
PEG	-	0.3x	-1.3x	-1.4x	7.71x	12.45x	0.8x	0.6x
Capitalization / Revenue	6.38x	2.35x	3.87x	4.22x	4.37x	3.8x	3.29x	3x
EV / Revenue	6.34x	2.29x	3.92x	4.33x	4.4x	3.78x	3.2x	2.81x
EV / EBITDA	20.3x	6.72x	13.3x	15.9x	15.1x	14.9x	11x	8.81x
EV / EBIT	22.7x	7.32x	14.8x	18.4x	17.6x	17.8x	12.7x	9.98x
EV / FCF	37.9x	10.1x	54.3x	43.5x	27.4x	15.8x	22.9x	16.6x
FCF Yield	2.64%	9.95%	1.84%	2.3%	3.65%	6.32%	4.36%	6.02%
Dividend per Share ²	0.9556	1.294	1.104	0.9351	0.9594	0.9804	1.169	1.354
Rate of return	1.29%	3.59%	1.83%	1.49%	1.51%	1.71%	2.04%	2.36%
EPS ²	2.76	3.73	3.2	2.67	2.75	2.795	3.388	4.146
Distribution rate	34.6%	34.7%	34.5%	35%	34.9%	35.1%	34.5%	32.6%
Net sales ¹	648.7	817.7	829.5	763.7	743.5	771.7	890.8	976.1
EBITDA ¹	202.9	278.7	244.5	207.4	216.2	195.7	258.6	310.9
EBIT ¹	181.5	255.8	220.1	179.4	185.8	163.5	223.7	274.4
Net income ¹	153.1	199.7	170.3	136.9	140.4	128.5	173.9	212.8
Net Debt ¹	-25.87	-52.78	38.6	85.1	23.84	-16.21	-81.51	-193.5
Reference price ²	73.80	36.06	60.20	62.95	63.50	57.35	57.35	57.35
Nbr of stocks (in thousands)	56,069	53,375	53,370	51,149	51,149	51,143	-	-
Announcement Date	23/02/22	21/02/23	27/02/24	25/02/25	24/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	31.77x	11.54x	23.41x	0.62%	99TCr
JOHNSON & JOHNSON	29.54x	-	-	2.02%	64TCr
ABBVIE INC.	32.92x	7.63x	15.78x	2.67%	45TCr
ROCHE HOLDING AG	18.71x	4.57x	11.31x	2.91%	34TCr
NOVARTIS AG	19.41x	5.08x	12.59x	3.21%	26TCr
ASTRAZENECA PLC	20.34x	4.19x	11.96x	2.11%	25TCr
AMGEN INC.	23.87x	6.3x	11.23x	2.67%	20TCr
NOVO NORDISK A/S	12.3x	4.48x	9.37x	4.08%	19TCr
GILEAD SCIENCES, INC.	-43.47x	6.35x	24.81x	2.29%	18TCr
Average	16.16x	6.27x	15.06x	2.51%	38.94TCr
Weighted average by Cap.	23.19x	7.72x	17.10x	2.05%